About US
Contact us
-
Eurofins Genomics Is First Genomics Service Provider in Germany to Achieve GLP CertificationEurofins Genomics is the first genomics service provider in Germany to achieve good laboratory practice (GLP) certification for DNA sequencing services. GLP is a required standard for laboratories co2014/11/13
-
FDA approves Amgen’s BLA for high cholesterol treatment evolocumabAmgen has received approval for review from US Food and Drug Administration (FDA) for its evolocumab to treat high cholesterol. The FDA accepted Biologics License Application (BLA) for evolocumab, an2014/11/13
-
Takeda and GE Healthcare partner to develop therapeutic drugs for liver diseasesJapan-based Takeda Pharmaceutical has signed an alliance agreement with GE Healthcare for research and development of hepatic fibrosis. Hepatic fibrosis is an important factor in the diagnosis and tr2014/11/13
-
7PSolutions Announces New Additions in Brazil and ChinaIn an ongoing effort to provide clients with uninterrupted visibility to global supply chains, 7PSolutions are proud to announce new additions to their global service offerings, in Brazil and China.2014/11/12
-
SMC approves BMS’ Daklinza and Yervoy to treat patients within NHS ScotlandThe Scottish Medicines Consortium (SMC) has approved Bristol-Myers Squibb's (BMS) Daklinza (daclatasvir) for use within NHS Scotland to treat adult patients with chronic hepatitis C. Daclatasvir rece2014/11/12
-
FDA approves Amgen’s BLA for high cholesterol treatment evolocumabAmgen has received approval for review from US Food and Drug Administration (FDA) for its evolocumab to treat high cholesterol. The FDA accepted Biologics License Application (BLA) for evolocumab, an2014/11/12
-
Perrigo to buy OTC drug-maker Omega Pharma for $4.5bnIreland-based Perrigo has signed an agreement to acquire Belgium's over-the-counter (OTC) drug-maker Omega Pharma, for €3.6bn ($4.5bn). The transaction includes the purchase of Omega's equity for €2.2014/11/11
-
Johnson & Johnson completes acquisition of Alios BioPharma for $1.75bnUS-based Johnson & Johnson (J&J) has completed the acquisition of a privately held clinical stage biopharmaceutical company, Alios BioPharma, for $1.75bn in cash. Based in California, US, Ali2014/11/11
-
Aegerion to acquire AstraZeneca’s lipodystrophy treatment Myalept for $325mAegerion Pharmaceuticals has signed an agreement to acquire an orphan product Myalept (metreleptin for injection) from AstraZeneca. AstraZeneca will receive $325m upfront payment to divest the rights2014/11/11
-
The International Clinical Trials Registry Platform – perils, pitfalls and possibilitiesAn intriguing study, published in the August edition of the journal PAIN, has shed new light on the issue of publication bias. Investigators using the World Health Organization’s International Clini2014/11/10